These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17665855)

  • 1. Influence of the type of cellulose on properties of multi-unit target releasing in stomach dosage form with verapamil hydrochloride.
    Sawicki W; Łunio R; Walentynowicz O; Kubasik-Juraniec J
    Acta Pol Pharm; 2007; 64(1):81-8. PubMed ID: 17665855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
    Sawicki W; Lunio R
    Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compressibility of gastroretentive pellets coated with Eudragit NE using a single-stroke and a rotary tablet press.
    Łunio R; Sawicki W; Skoczeń P; Walentynowicz O; Kubasik-Juraniec J
    Pharm Dev Technol; 2008; 13(4):323-31. PubMed ID: 18649222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the components of Kollicoat SR film on mechanical properties of floating pellets from the point of view of tableting.
    Lunio R; Sawicki W
    Pharmazie; 2008 Oct; 63(10):731-5. PubMed ID: 18972835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multifunctional pharmaceutical excipients derived from microcrystalline cellulose-starch microparticulate composites prepared by compatibilized reactive polymer blending.
    Builders PF; Bonaventure AM; Tiwalade A; Okpako LC; Attama AA
    Int J Pharm; 2010 Mar; 388(1-2):159-67. PubMed ID: 20060448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D; Kleinebudde P
    Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release pellets based on poly(N-isopropyl acrylamide): matrix and in situ photopolymerization-coated systems.
    Mayo-Pedrosa M; Alvarez-Lorenzo C; Lacík I; Martinez-Pacheco R; Concheiro A
    J Pharm Sci; 2007 Jan; 96(1):93-105. PubMed ID: 16967440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs.
    Chopra S; Venkatesan N; Betageri GV
    Int J Pharm; 2013 Mar; 446(1-2):136-44. PubMed ID: 23422274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the degree of polymerization on the behavior of cellulose during homogenization and extrusion/spheronization.
    Kleinebudde P; Jumaa M; El Saleh F
    AAPS PharmSci; 2000; 2(3):E21. PubMed ID: 11741237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the porosity of cushioning excipients on the compaction of coated multi-particulates.
    Elsergany RN; Chan LW; Heng PWS
    Eur J Pharm Biopharm; 2020 Jul; 152():218-228. PubMed ID: 32445966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of floating pellets with verapamil hydrochloride.
    Sawicki W; Głód J
    Acta Pol Pharm; 2004; 61(3):185-90. PubMed ID: 15481243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
    Sahoo J; Murthy PN; Biswal S; Manik
    AAPS PharmSciTech; 2009; 10(1):27-33. PubMed ID: 19145487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the tabletting behaviour of microcrystalline cellulose pellets by the incorporation of polyethylene glycol.
    Nicklasson F; Alderborn G
    Eur J Pharm Sci; 1999 Oct; 9(1):57-65. PubMed ID: 10493997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW; Koo OM
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.